PubMed Health⌕ Search

Biomedical subjects

I M Parsonson

Publications and source records attributed to I M Parsonson.

At least 19 recordsLinked to original sources
PubMed1991

Temporal relationships of viremia, interferon activity, and antibody responses of sheep infected with several bluetongue virus strains.

Sheep had viremias that were first detected on day 3 (+/- 1) after infection with several strains of bluetongue virus (BTV) representing United States serotypes 10, 11, 13, and 17. Diphasic peaks of infectivity were attained on days 6 and 10 (+/- 2). Interferon (IFN) was first detected in serum samples on day 5 (+/- 1), and reached greatest concentrations on day 6 (+/- 2), which coincided with the first viremic peak; IFN concentrations then decreased toward zero by day 10 (+/- 2). Interferon peak concentrations induced approximately a 90% decrease in virus titer. The decrease in IFN concentrations by day 9 (+/- 2) corresponded with the second viremic peak on day 10 (+/- 2). Onset of the decrease in detectable concentrations of virus after the second peak of viremia corresponded to the initial detection of serum antibody to BTV by day 10 (+/- 2). Virus titer decreased and antibody production increased until approximately days 21 to 28, when the titers plateaued and virus was not detected. Febrile responses peaked on day 7 (+/- 1) during the peak viremic period. The WBC count was depressed at the time the virus titer increased, but returned to normal values while the sheep were still viremic. Diphasic viremias in BTV-infected sheep were attributed to induction of high concentrations of IFN concurrent with the first virus titer peak, followed by production of antibody to specific BTV strains and a subsequent reduction in viremia at the second virus titer peak.

Animals↗
PubMed1988

Maturation of immunological reactivity in the fetal lamb infected with Akabane virus.

The development of cell-mediated immunological reactivity was studied in fetal lambs infected with Akabane virus. Examination of hepatic cells from fetuses between 40 and 75 days' gestation that had been infected via the transplacental route revealed inconsistent responses to Akabane, together with a uniform failure to respond to non-specific mitogens which contrasted with the behaviour of control, uninfected lambs. Following direct inoculation of fetal lambs with virus between 50 and 120 days' gestation, specific proliferative responses were observed on the part of the spleen cells from some. Direct challenge of fetal lambs of 4 months' gestation evoked cellular responses in lymph draining from the site of virus inoculation similar to those produced by challenge of adult sheep. The proliferative response of lymph-borne cells was substantially better if live, rather than inactivated, virus had been used.

Animals↗
PubMed1988

Transmission of Akabane virus from the ewe to the early fetus (32 to 53 days).

The role of the placental junction in AKA virus infection in the ewe was examined during the time when the chorionic villi were first becoming firmly attached to the maternal caruncles. The studies were made over 21 days covering the period between 32 and 53 days of pregnancy. Viral tropism in the fetal membranes and tissues of the fetuses was identified by virus isolation and immuno-fluorescence studies. Areas of virus replication were noted from 24 h post-inoculation in the fetal membranes and persisted in these tissues throughout the experiment. Viral antigen was first detected in the fetus from day 5 post-inoculation by virus isolation and immuno-fluorescence. From this time on, viral activity increased in specific areas of the fetus, notably in the brain and, to a lesser extent, the skeletal muscles. Gross pathological changes occurred in the fetuses between day 14 and day 21 post-inoculation (46 to 53 days gestation). Despite the relatively high titres of AKA virus present in the placental tissues and the developmental changes occurring in the fetus due to the virus, the placental junction continued to carry out its physiological function of maintaining pregnancy.

Animals↗
PubMed1987

Experimental infection of bulls and cows with bluetongue virus serotype 20.

Bluetongue virus serotype 20 (BTV20) was inoculated intradermally and subcutaneously in 4 bulls and by the intrauterine route in 8 nulliparous cows after insemination at oestrus. Viraemia was detected intermittently between 8 and 21 days after inoculation. Virus was isolated from tissue samples of 2 cows and a bull after slaughter at 14 days and from one bull at 28 days. Group reactive and type specific antibodies to BTV20 were demonstrated from 17 to 27 days after infection. No antibodies were detected in the animals slaughtered at 14 days. No clinical signs of disease were seen during the experiment and no gross or histopathological changes referable to BTV20 infection were observed post-mortem. Because of the viraemia and the production of detectable serum antibodies, gametes from these cattle would be excluded from export.

Animals↗
PubMed1987

Bluetongue virus serotype 20: experimental infection of pregnant heifers.

Three groups of 4 cows at 84 to 95 days, 100 to 160 days, and 170 to 180 days pregnant were inoculated both intradermally and subcutaneously with bluetongue virus serotype 20 (BTV20). Clinical observations and the viraemic and serological responses of the cows were followed for 9 to 17 weeks after inoculation. Viraemia developed in 9 of the 12 cows and was first detected 4 to 9 days after inoculation. Viraemia was detected for 4 to 21 days and in some animals only intermittently. The titre of the viraemia was obtained in 4 cows and ranged from detectable only, to 10(1) to 10(2.8) 50% tissue culture infecting doses per ml. Both serum neutralising and precipitating antibodies were detected in 11 of the 12 cows within 2 to 8 weeks after inoculation. No clinical responses were seen and one cow (516) did not develop a viraemia or produce detectable antibodies to the virus. The cows, calves and foetuses were necropsied following either parturition or slaughter between 200 and 270 days of pregnancy. No virus isolations were made from a wide range of tissues from the cows, calves or foetuses and no immunoglobulins or serum neutralising antibodies were detected in the serums of precolostral calves or foetuses at necropsy. No gross or histopathological lesions were seen in the cows, calves or foetuses, and there was no evidence that BTV20 crossed the bovine placenta or infected the foetus.

Animals↗
PubMed1986

The pathogenicity of an avian influenza virus isolated in Victoria.

An influenza virus (H7N7) isolated from an outbreak of disease in chickens in Victoria, was examined for its ability to cause disease in inoculated chickens, turkeys and ducks. The virus was highly pathogenic in chickens and turkeys but produced no clinical disease in ducks. Transmission of infection occurred from inoculated chickens to those in direct contact but other chickens separated by a distance of 3m directly downwind developed neither clinical disease nor antibody to the virus.

Animals↗
PubMed1986

Responses of cattle, sheep and poultry to a recombinant vaccinia virus expressing a swine influenza haemagglutinin.

Groups of cattle, sheep and poultry were inoculated with a recombinant vaccinia virus expressing the haemagglutinin of the swine influenza virus A/NJ/11/76. No adverse clinical responses were recorded and none of the animals developed a viraemia when inoculated with the recombinant or wild-type vaccinia virus. Recombinant virus reisolated from lesions in cattle was stable, maintaining its thymidine kinase negative phenotype and ability to express the swine influenza haemagglutinin. Antibodies to the influenza haemagglutinin were detected in cattle, sheep and poultry inoculated with the recombinant virus. While no animals inoculated with wild-type virus developed these antibodies, there was no detectable spread of either recombinant or wild-type virus from the inoculation sites or to in-contact uninoculated animals. The results indicate that recombinant vaccinia viruses can induce immune responses in cattle, sheep and poultry demonstrating their potential as vaccine vectors in a variety of important veterinary species.

Animals↗
PubMed1985

Bluetongue, epizootic haemorrhagic disease of deer and related viruses: current situation in Australia.

Since 1975 3 serotypes of bluetongue (BT) virus (BTV) have been identified in Australia: BTV1 (CSIRO156), BTV20 (CSIRO19) and BTV21. At present 2 further BT viruses (DPP90 and DPP192) have been isolated from the blood of healthy cattle in the Northern Territory (NT) and are undergoing identification. There is serological evidence for BTV15 infection in Western Australia (WA) and the NT, and a background level of serological activity to BTV serotypes 1 to 17. In addition, over 50 isolations of epizootic hemorrhagic disease of deer (EHD) viruses (EHDV) have been made and can be divided into 5 main serotypes, CSIRO157, CSIRO439, CSIRO753, CSIRO775 and DPP59. All 5 serotypes occur within the ecological range of Culicoides brevitarsis, however, as for BTV, the high prevalence of antibodies in cattle in the Kimberley region of WA and the top end of the NT suggests other vectors may also be responsible. CSIRO439 has been shown to be closely related serologically to Ibaraki virus while the other EHD viruses were distinct from Ibaraki and from each other. The complex serological relationships between BTV, EHDV and Palyam virus groups are currently being examined using serological and biochemical techniques. It is often difficult to determine the differences between BTV and EHDV serogroup members. Antibodies to both BTV and EHDV have been found in cattle, buffaloes and deer but there has been no evidence of clinical disease in any of these species or in sheep under field conditions in Australia.

Animals↗
PubMed1985

Problems in the interpretation of diagnostic tests due to cross-reactions between orbiviruses and broad serological responses in animals.

Tests presently used for the diagnosis of infections by bluetongue virus (BTV) or related orbiviruses are based on the use of 2 types of serological reactions. Those that are considered group-reactive tests are the agar gel diffusion precipitin (AGDP), complement-fixation (CF) and fluorescent antibody tests and those that are considered type-specific are a wide variety of virus neutralization tests (50% and 80% plaque reduction, plaque inhibition and microtiter neutralization) and cross-protection tests. These tests suffer from problems of standardization between laboratories and of specificity. Group-reactive tests (AGDP and CF) for the BTV serogroup also detect cross-reactions with viruses in the epizootic hemorrhagic disease virus (EHDV), Eubenangee (EUB) and Palyam (PAL) serogroups, with the EHDV cross-reactions being of particular concern. Further, multiple infections of cattle with PAL serogroup members can produce antibodies which will react to BTV and EHDV serogroup antigens in serological tests. Multiple infections of animals with related viruses can produce antibodies which will cross-react with orbiviruses in type-specific, virus neutralization tests to a virus which the animal has not previously been exposed. These observations stress the need to evaluate the tests at present being used, to assess the risks of cross-reactions between related orbiviruses and to develop new tests of defined specificity.

Animals↗
PubMed1983

Bluetongue virus serotype 20 infections in cattle of breeding age.

Ten cattle (6 heifers and 4 bulls) were inoculated with bluetongue virus (BTV) type 20. Clinical signs, antibody responses, and capabilities of these animals to replicate and maintain virus were assessed. The cattle showed no clinical signs of disease, although they did develop antibodies to BTV which showed long-term increasing titers. Virus was intermittently isolated from samples of blood, but not beyond day 21. Virus was not detected in the semen of the bulls, nor isolated from the tissues of the cattle at necropsy except from the genital tract of the 2 bulls which had been killed within 30 days after their inoculation. Gross and microscopic pathologic changes were not seen in any tissues that were attributable to BTV infection. There was no evidence of damage to the reproductive organs or of the development of a latent carrier state in either the heifers or the bulls.

Animals↗
PubMed1982

Bluetongue virus serotypes 20 and 17 infections in sheep: comparison of clinical and serological responses.

The clinical, virological and serological responses of sheep infected with an Australian bluetongue virus (BTV) isolate (serotype 20) were compared to responses in sheep inoculated with an American bluetongue isolate (serotype 17) with which it had shown cross-reactions in serum neutralization tests. In sheep inoculated with BTV 20, clinical signs were very mild and viremia was first detected by day 5; virus was isolated intermittently for a further 2 to 3 days. Neutralizing and precipitating antibodies were first detected in the serum of the sheep between 2 to 3 weeks following inoculation. In contrast, sheep inoculated with BTV 17 showed pyrexia and severe hyperemia of the nasolabial area and oral mucosa from day 7 to 17. Viremia was first detected on day 3 and extended to day 20, while the appearance and titers of serum antibodies was similar in both groups. After challenge with BTV 17 the sheep in both groups remained clinically normal, and virus was not detected in the blood; however, serum neutralizing antibody titers to both viruses increased 2 weeks after challenge and the mean titer of the two groups ranged from 1:250 to 1:640.

Animals↗
PubMed1982

Comparative studies on the growth of Australian bluetongue virus serotypes in continuous cell lines and embryonated chicken eggs.

The replication of cell culture passaged Australian bluetongue virus (BTV) isolates, serotypes 20 (CSIRO19) and 1 (CSIRO156), and an untyped BTV (CSIRO154) was assessed in eight continuous cell lines (one derived from baby hamster kidney cells, BHK-21; three derived from monkey kidney cells, Vero, LLC-MK2 and CV-1P; a foetal ovine lung and a mouse fibroblast cell line, CSL503 and L929, respectively, a Super-Vero-Porcine stable cell line, SVP; and a mosquito cell line, Aedes albopictus cells) and in 11-day-old embryonated chicken eggs (ECE) at different multiplicities of infection. All three viruses replicated in the cell lines tested, maximum extracellular virus yields being attained from BHK-21 cells at high multiplicities of infection (approximately 10 PFU per cell). Also BHK-21 cells produced much higher yields of virus than the other cell lines tested when low multiplicities of infection were used (approximately 10(-4) PFU per cell). All BTV serotypes multiplied in Singh's Aedes albopictus cells with no cytopathogenic effects over the 4 day period tested. The viruses also replicated in 11-day-old ECE; however, the sensitivity of ECE for growth of the Australian serotypes was not as high as has been reported for BTV isolates in other countries. In all cell culture systems and in ECE, BTV1 and BTV20 replicated more efficiently than did CSIRO154 virus.

Aedes↗